Transdermally applied iloprost (ZK36-374) decreases whole blood platelet aggregation in normal volunteers

Jill Belch, D. Ansell, A. Saniabadi, C. D. Forbes, R. D. Sturrock

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

    2 Citations (Scopus)
    Original languageEnglish
    Title of host publicationProstaglandins in clinical research
    Subtitle of host publicationproceedings of the 3rd International Symposium on Prostaglandins, held in Bad Ischl, Austria, September 16-20, 1986
    EditorsHelmut Sinzinger, Karsten Schror
    Place of PublicationNew York
    PublisherLiss Publisher
    Pages413-417
    Number of pages5
    ISBN (Print)9780845150924
    Publication statusPublished - 1987
    Eventc, held in Bad Ischl, Austria, September 16-20, 1986 - Bad Ischl, Austria
    Duration: 16 Sep 198620 Sep 1986

    Publication series

    NameProgress in Clinical and Biological Research
    Number242

    Conference

    Conferencec, held in Bad Ischl, Austria, September 16-20, 1986
    CountryAustria
    CityBad Ischl
    Period16/09/8620/09/86

    Cite this

    Belch, J., Ansell, D., Saniabadi, A., Forbes, C. D., & Sturrock, R. D. (1987). Transdermally applied iloprost (ZK36-374) decreases whole blood platelet aggregation in normal volunteers. In H. Sinzinger, & K. Schror (Eds.), Prostaglandins in clinical research: proceedings of the 3rd International Symposium on Prostaglandins, held in Bad Ischl, Austria, September 16-20, 1986 (pp. 413-417). (Progress in Clinical and Biological Research; No. 242). Liss Publisher. http://europepmc.org/abstract/MED/2444992/reload=0;jsessionid=Ma6nuQcdFLvUsEcYDc0u.18